IT8548055A1 - Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale - Google Patents

Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale

Info

Publication number
IT8548055A1
IT8548055A1 IT1985A48055A IT4805585A IT8548055A1 IT 8548055 A1 IT8548055 A1 IT 8548055A1 IT 1985A48055 A IT1985A48055 A IT 1985A48055A IT 4805585 A IT4805585 A IT 4805585A IT 8548055 A1 IT8548055 A1 IT 8548055A1
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
involutive
therapy
brain syndrome
mental
Prior art date
Application number
IT1985A48055A
Other languages
English (en)
Other versions
IT1199972B (it
IT8548055A0 (it
Original Assignee
Soc Lpb St Farmaceutico S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Lpb St Farmaceutico S P A filed Critical Soc Lpb St Farmaceutico S P A
Publication of IT8548055A0 publication Critical patent/IT8548055A0/it
Priority to IT48055/85A priority Critical patent/IT1199972B/it
Priority to JP60167847A priority patent/JPS61257924A/ja
Priority to US06/760,955 priority patent/US4624946A/en
Priority to ZA855822A priority patent/ZA855822B/xx
Priority to AU46206/85A priority patent/AU564439B2/en
Priority to EP85110904A priority patent/EP0201623B1/en
Priority to DE8585110904T priority patent/DE3575859D1/de
Priority to AT85110904T priority patent/ATE50143T1/de
Priority to CA000495665A priority patent/CA1258233A/en
Publication of IT8548055A1 publication Critical patent/IT8548055A1/it
Application granted granted Critical
Publication of IT1199972B publication Critical patent/IT1199972B/it
Priority to MX9203374A priority patent/MX9203374A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IT48055/85A 1985-05-08 1985-05-08 Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale IT1199972B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT48055/85A IT1199972B (it) 1985-05-08 1985-05-08 Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
JP60167847A JPS61257924A (ja) 1985-05-08 1985-07-31 脳衰退症状及び精神的衰微を治療するための医薬組成物
US06/760,955 US4624946A (en) 1985-05-08 1985-07-31 Treatment of involutional brain syndromes and mental decay
ZA855822A ZA855822B (en) 1985-05-08 1985-08-01 Pharmaceutical compositions for the treatment of involutional brain syndromes and mental decay
AU46206/85A AU564439B2 (en) 1985-05-08 1985-08-13 Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
EP85110904A EP0201623B1 (en) 1985-05-08 1985-08-29 Pharmaceutical compositions for the treatment of involutional brian syndromes and mental decay
DE8585110904T DE3575859D1 (de) 1985-05-08 1985-08-29 Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
AT85110904T ATE50143T1 (de) 1985-05-08 1985-08-29 Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
CA000495665A CA1258233A (en) 1985-05-08 1985-11-19 Pharmaceutical compositions for the treatment of involutional brain syndromes and mental decay
MX9203374A MX9203374A (es) 1985-05-08 1992-06-25 Composicion farmaceutica que contiene l-alfa-glicerofosforilcolina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48055/85A IT1199972B (it) 1985-05-08 1985-05-08 Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale

Publications (3)

Publication Number Publication Date
IT8548055A0 IT8548055A0 (it) 1985-05-08
IT8548055A1 true IT8548055A1 (it) 1986-11-08
IT1199972B IT1199972B (it) 1989-01-05

Family

ID=11264232

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48055/85A IT1199972B (it) 1985-05-08 1985-05-08 Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale

Country Status (10)

Country Link
US (1) US4624946A (it)
EP (1) EP0201623B1 (it)
JP (1) JPS61257924A (it)
AT (1) ATE50143T1 (it)
AU (1) AU564439B2 (it)
CA (1) CA1258233A (it)
DE (1) DE3575859D1 (it)
IT (1) IT1199972B (it)
MX (1) MX9203374A (it)
ZA (1) ZA855822B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942165A (en) * 1986-02-11 1990-07-17 Advanced Biologics, Inc. Treatment for Alzheimer's disease
IT1213034B (it) * 1986-02-12 1989-12-07 Istituto Chemioterapico Di Lod Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
IT1212137B (it) * 1987-04-08 1989-11-08 Rosanna Lodi Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
EP0329053A1 (en) * 1988-02-15 1989-08-23 MAGIS FARMACEUTICI S.p.A. Choline esters of glycerophosphoric acids
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
ITMI20131219A1 (it) * 2013-07-19 2015-01-20 Ricerfarma Srl Colina alfoscerato come inibitore di ialuronidasi
KR101864384B1 (ko) 2017-12-11 2018-06-04 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 쥐남의 치료, 개선 또는 예방용 조성물 및 방법
KR101841654B1 (ko) 2017-12-19 2018-03-26 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 신경병증성 통증의 치료, 개선 또는 예방용 조성물 및 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54117034A (en) * 1978-02-28 1979-09-11 Nippon Shoji Kk Treating agent for consciousness and perception motion disorder
JPS5566512A (en) * 1978-11-15 1980-05-20 Massachusetts Inst Technology Method and composition for treating difficulties by administration of choline or choline dissociating compound
GB2045612B (en) * 1979-03-27 1983-04-20 Nippon Shoji Kaisha Ltd Pharmaceutical compositions containing phosphatidic acids for the treatment of disorders of consciousness perception and movement
IT1123142B (it) * 1979-09-14 1986-04-30 Lpb Ist Farm Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative

Also Published As

Publication number Publication date
ATE50143T1 (de) 1990-02-15
JPS61257924A (ja) 1986-11-15
EP0201623A1 (en) 1986-11-20
US4624946A (en) 1986-11-25
AU4620685A (en) 1986-11-13
IT1199972B (it) 1989-01-05
ZA855822B (en) 1986-03-26
MX9203374A (es) 1992-09-01
IT8548055A0 (it) 1985-05-08
DE3575859D1 (de) 1990-03-15
EP0201623B1 (en) 1990-02-07
AU564439B2 (en) 1987-08-13
CA1258233A (en) 1989-08-08
JPH0228580B2 (it) 1990-06-25

Similar Documents

Publication Publication Date Title
IT8027029A0 (it) Complessi platino-diamminici e formulazioni farmaceutiche per il trattamento del cancro che licontengono.
SE8501050D0 (sv) Biologically active fragments of human antihemophilic factor and method for preparation thereof
IT8548055A1 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
IT8521322A0 (it) Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche.
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
DE68900926D1 (de) Pharmazeutische zubereitung, die zidovudin und inosiplex oder bestandteile davon enthaelt, fuer die behandlung von aids-verwandten syndromen.
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
DE3879837D1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
IT8467950A0 (it) Procedimento e dispositivo per il trattamento del plasma sanguigno
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
DE3879709D1 (de) Platin-arzneimittel.
DE3579074D1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
DK222988D0 (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
GR880100401A (el) 8α-ακυλαμινεργολινη,παρασκευη της και φαρμακευτικες συνθεσεις που την περιεχουν.
IT8322949A0 (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
IT1171692B (it) Preparato farmaceutico impiegabile per il trattamento della lebbra e/o di altre micobatteriosi
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure
IT8647656A0 (it) Combinazione di analgesico centrale ed adenina per il trattamento analgesico del corpo umano o animale e composizione farmaceutica che la contiene
NL185666C (nl) Farmaceutisch preparaat of voorwerp en geneeskrachtige verbindingen.